A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions.
暂无分享,去创建一个
David Buttar | S. Steinbacher | A. Plowright | P. Macfaul | D. Buttar | H. Steuber | S. Gerhardt | K. Tam | K. Maskos | N. Colclough | Holger Steuber | Stefan Gerhardt | Nicola Colclough | S. D. Phillips | Stefan Steinbacher | Klaus Maskos | Philip A MacFaul | Scott D Phillips | Alleyn Plowright | Paul Whittamore | Kin Tam | P. Whittamore | S. Phillips
[1] I. Sjöholm,et al. Binding of drugs to human serum albumin:XI. The specificity of three binding sites as studied with albumin immobilized in microparticles. , 1979, Molecular pharmacology.
[2] N. Kishore,et al. Calorimetric and spectroscopic studies on the interaction of methimazole with bovine serum albumin. , 2008, Journal of pharmaceutical sciences.
[3] S. Tanase,et al. Role of arg-410 and tyr-411 in human serum albumin for ligand binding and esterase-like activity. , 2000, The Biochemical journal.
[4] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[5] O. Dangles,et al. Flavonoid-serum albumin complexation: determination of binding constants and binding sites by fluorescence spectroscopy. , 2005, Biochimica et biophysica acta.
[6] G N Murshudov,et al. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. , 2001, Acta crystallographica. Section D, Biological crystallography.
[7] M. J. Crooks,et al. Displacement of tolbutamide, glibencalmide and chlorpropamide from serum albumin by anionic drugs. , 1976, Biochemical pharmacology.
[8] Alexander Tropsha,et al. QSAR modeling of human serum protein binding with several modeling techniques utilizing structure-information representation. , 2006, Journal of medicinal chemistry.
[9] L. Calabi,et al. A molecular dynamics study of human serum albumin binding sites. , 2005, Farmaco.
[10] P. Welling,et al. Evidence for isoxicam binding to site I as a primary site and to site II as a secondary site of human serum albumin. , 1989, Biochemical pharmacology.
[11] J. Tillement,et al. The binding characteristics of some adrenergic beta-receptor antagonists to human serum proteins. , 1982, Biochemical Pharmacology.
[12] M. Jiménez,et al. Use of Triplet Excited States for the Study of Drug Binding to Human and Bovine Serum Albumins , 2006, ChemMedChem.
[13] G. Trainor,et al. The importance of plasma protein binding in drug discovery , 2007, Expert opinion on drug discovery.
[14] Thomas J. Raub,et al. A General, Wide-Range Spectrofluorometric Method for Measuring the Site-Specific Affinities of Drugs toward Human Serum Albumin , 1995 .
[15] M. Otagiri,et al. Characterization of site I on human serum albumin: concept about the structure of a drug binding site. , 1996, Biochimica et biophysica acta.
[16] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .
[17] D. L. Parsons,et al. Human Albumin Binding of Tamoxifen in the Presence of a Perfluorochemical Erythrocyte Substitute , 1991, The Journal of pharmacy and pharmacology.
[18] M. Abraham,et al. Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity. , 2003, Journal of pharmaceutical sciences.
[19] D G Myszka,et al. High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE. , 2001, Analytical biochemistry.
[20] Markus Kroemer,et al. APRV - a program for automated data processing, refinement and visualization. , 2004, Acta crystallographica. Section D, Biological crystallography.
[21] F. Lapicque,et al. Binding Sites of Fluorescent Probes on Human Serum Albumin , 1994, The Journal of pharmacy and pharmacology.
[22] Guoquan Liu,et al. Determining binding sites of drugs on human serum albumin using FIA-QCM. , 2008, Biosensors & bioelectronics.
[23] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[24] Manfred Kansy,et al. Predicting plasma protein binding of drugs: a new approach. , 2002, Biochemical pharmacology.
[25] P. Brooks,et al. Structural requirements for drug binding to site II on human serum albumin. , 1983, Molecular pharmacology.
[26] John E. Schiel,et al. Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin: characterization by high-performance affinity chromatography. , 2009, Journal of chromatography. A.
[27] W. Müller,et al. The location of drug binding sites in human serum albumin. , 1981, Biochemical pharmacology.
[28] Bruce G. Jenkins,et al. Detection of site-specific binding and co-binding of ligands to human serum albumin using 19F NMR. , 1990, Molecular pharmacology.
[29] Fredrik Bergström,et al. High Throughput Screening of Drug‐Protein Binding in Drug Discovery , 2007 .
[30] C. Chignell,et al. RECENT ADVANCES IN METHODOLOGY: SPECTROSCOPIC TECHNIQUES , 1973 .
[31] T. Soulimane,et al. A novel free-mounting system for protein crystals: transformation and improvement of diffraction power by accurately controlled humidity changes , 2000 .
[32] E. Lui,et al. Functional modification of indole binding site with indomethacin congeners. , 1977, Journal of pharmaceutical sciences.
[33] S. Curry,et al. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis. , 2006, Journal of molecular biology.
[34] U. Wollert,et al. Characterization of the binding of benzodiazepines to human serum albumin , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.
[35] R. Brodersen,et al. Albumin binding of anti-inflammatory drugs. Utility of a site-oriented versus a stoichiometric analysis. , 1984, Molecular pharmacology.
[36] K. Paal,et al. Paclitaxel binding to the fatty acid-induced conformation of human serum albumin--automated docking studies. , 2007, Bioorganic & medicinal chemistry.
[37] M. Koupparis,et al. In‐vitro study on the competitive binding of diflunisal and uraemic toxins to serum albumin and human plasma using a potentiometric ion‐probe technique , 2006, The Journal of pharmacy and pharmacology.
[38] S. Curry,et al. Structural basis of the drug-binding specificity of human serum albumin. , 2005, Journal of molecular biology.
[39] D. Carter,et al. Atomic structure and chemistry of human serum albumin , 1992, Nature.
[40] T. Horie,et al. Fluorescence energy transfer study of the relationship between the lone tryptophan residue and drug binding sites in human serum albumin. , 1987, Journal of pharmaceutical sciences.
[41] G M Pacifici,et al. Methods of Determining Plasma and Tissue Binding of Drugs , 1992, Clinical pharmacokinetics.
[42] Manfred Kansy,et al. Predicting plasma protein binding of drugs--revisited. , 2004, Current opinion in drug discovery & development.
[43] H. Tajmir-Riahi,et al. Study of curcumin and genistein interactions with human serum albumin. , 2009, Journal of pharmaceutical and biomedical analysis.
[44] W. Müller,et al. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone. , 1982, Molecular pharmacology.
[45] G. Sudlow,et al. The characterization of two specific drug binding sites on human serum albumin. , 1975, Molecular pharmacology.
[46] S. Curry,et al. Crystallographic Analysis of Human Serum Albumin Complexed with 4Z,15E-Bilirubin-IXα , 2008, Journal of molecular biology.
[47] P. Hajduk,et al. Rational design of diflunisal analogues with reduced affinity for human serum albumin. , 2001, Journal of the American Chemical Society.
[48] G. Sudlow,et al. Further characterization of specific drug binding sites on human serum albumin. , 1976, Molecular pharmacology.
[49] A. Douhal,et al. Relaxation dynamics of piroxicam structures within human serum albumin protein. , 2007, Journal of medicinal chemistry.
[50] A. Pîrnău,et al. Binding interaction of indomethacin with human serum albumin. , 2008, Journal of pharmaceutical and biomedical analysis.
[51] N. Pescosolido,et al. An NMR spectroscopy study of bendaline-albumin interactions. , 2003, Bioorganic chemistry.